Research for a Future
without Diabetes

„Research for a future without diabetes – this is the mission of the DZD that inspires and unites us.“

Prof. Martin Hrabě de Angelis, DZD board member

Research for a Future
without Diabetes

„The Germany-wide cooperation in the DZD ensures that multicenter studies can be carried out with the required number of participants.“

Prof. Michael Roden, DZD board member

Research for a Future
without Diabetes

„The DZD places particular importance on the fast transfer of lab results to patient care.“

Prof. Michele Solimena, DZD speaker

„The special feature of research at the DZD is the close interdisciplinary cooperation between different disciplines.“

Prof. Annette Schuermann, DZDSpeaker

DZD - German Center
for Diabetes Research

Press Releases 2018

Potsdam-Rehbrücke, 31.05.2018

Heart Attack and Stroke Risk Also Elevated in Women with Obesity Who Are Metabolically Healthy

Women with obesity are at increased risk of cardiovascular disease, even if they are considered to be metabolically healthy. Moreover, women of normal weight are at risk of heart attack or stroke if they suffer from a metabolic disease such as diabetes or high blood pressure. These are the results of an analysis conducted by scientists of the German Institute of Human Nutrition (DIfE), Harvard University and University Hospital Tübingen based on 90,257 data records of a large U.S. cohort study. The researchers have now published their findings in the journal 'The Lancet Diabetes & Endocrinology'.

more

Neuherberg, 22.05.2018

Abdominal Fat Secretes Novel Adipokine Promoting Insulin Resistance and Inflammation

An international research team in which the DZD is participating has identified a novel adipokine that favors the development of insulin resistance and systemic inflammation. In cases of severe obesity, this adipokine is secreted by the adipocytes of the abdominal fat tissue and released into the bloodstream. The new findings could contribute to the development of alternative approaches for the treatment of diseases caused by obesity. The researchers have now published their results in the journal 'Diabetologia' (Hörbelt et al, 2018) of the European Association for the Study of Diabetes (EASD).

more

Düsseldorf, 18.05.2018

Motivating Kids to Discover the Fun of Exercise

Together with the Football Factory, the SMS initiative organized a one-day football camp for the participating primary school children.

more

Düsseldorf, 22.03.2018

Mastering the School Day with a Well-Balanced Diet

The “aid” nutrition pilot license program is carried out in the participating primary school classes of the SMS initiative.

more

Neuherberg, 14.03.2018

DZD Researcher Tim Schulz Awarded Paul Ehrlich and Ludwig Darmstaedter Prize for Young Researchers

The 2018 Paul Ehrlich and Ludwig Darmstaedter Prize for Young Researchers will be awarded today to Professor Tim Schulz in recognition of his biomedical research on the function of brown and white adipocytes (fat cells). At the German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), a partner of the DZD, Schulz is investigating how the different types of fat cells develop and what physiological or pathological effects they have. The award, endowed with 60,000 euros, will be presented in the Paulskirche in Frankfurt.

more

Düsseldorf, 09.03.2018

Diabetes Prevention through Fun Exercise Activities

The Düsseldorf Sports Club 1899 invites the primary school children participating in the SMS initiative to a taster hockey training session.

more

Düsseldorf, 27.02.2018

Cooking for a Balanced Lifestyle

KochDichTurkish offers the participating pupils of the SMS initiative a cooking course for kids.

more

Düsseldorf, 26.02.2018

Olympic Champion Supports Diabetes Prevention

Udo Hempel highlights the fascination of sports in a talk to primary school children participating in the SMS initiative.

more

Dresden, 19.02.2018

How the insulin receptor works

As we are approaching the 100th anniversary of the discovery of insulin, a wide array of its signaling pathways has been defined. However, the initial step in insulin action, i.e. the engagement with its cell-surface receptor and the resulting conformational change, which propagates across the plasma membrane to the intracellular module, remains poorly understood. Addressing this problem, researchers from the Paul Langerhans Institute Dresden of the Helmholtz Zentrum München at the University Hospital Carl Gustav Carus of TU Dresden together with colleagues from Rockefeller University New York succeeded for the first time in the visualization of the insulin receptor activation. The results of this collaborative work have now been published in the ‘Journal of Cell Biology’.

more

Neuherberg, 02.02.2018

Type 2 Diabetes: the Costs of Treating Complications

Scientists at the Helmholtz Zentrum München have examined health insurance data of more than 300,000 people with diabetes in Germany. Their report, published in the medical journal ‘Diabetes Care’, breaks down the costs involved in treating various complications of the disease. The Helmholtz authors are members of the German Center for Diabetes Research (DZD).

more

Tübingen/Neuherberg, 29.01.2018

Prostate Cancer: Poor Prognosis in Men with Diabetes

Men with type 2 diabetes are less likely to develop prostate cancer than patients without diabetes. However, the mortality rate is higher. Researchers of the German Center for Diabetes Research (DZD) from Tübingen and experts of Helmholtz Zentrum München and the Urology Department of Tübingen University Hospital were able to show that in the affected individuals the androgen receptor and the mitogenic forms of the insulin receptor were more strongly expressed. This could explain why patients with diabetes have a poorer prognosis for prostate cancer. The current results were published in the journals "Molecular Metabolism" and "Endocrine Related Cancer".

more

Neuherberg, 19.01.2018

Study decodes new diabetes genes

Scientists have identified a network of genes that could play an important role in the development of metabolic diseases such as diabetes. A research team from the Helmholtz Center Munich and the International Mouse Phenotyping Consortium (IMPC) led the work that is published in 'Nature Communications'.

more

Düsseldorf, 19.01.2018

Maren Carstensen-Kirberg Receives Award from Dr. Eickelberg Foundation for Biomarker Research

Dr. Maren Carstensen-Kirberg, research associate at the German Diabetes Center (DDZ), has been awarded the Dr. Eickelberg Foundation Prize 2017 for her research into biomarkers. An interdisciplinary team received the project grant for their project investigating the importance of the pro-inflammatory effect of the biomarker omentin on cells in adipose tissue.

more

Düsseldorf, 02.01.2018

Donation to Promote Diabetes Prevention

The Glomm Bakery and Pastry Shop and Fortuna Düsseldorf Clubhaus Bar95 support the SMS initiative.

more

Neuherberg, 04.01.2018

Autoimmune Reaction Successfully Halted in Early Stage Islet Autoimmunity

Scientists at Helmholtz Zentrum München have discovered a mechanism that amplifies the autoimmune reaction in an early stage of pancreatic islet autoimmunity prior to the progression to clinical type 1 diabetes. If the researchers blocked the corresponding molecules, the immune system was significantly less active. The study was conducted under the auspices of the German Center for Diabetes Research (DZD) and was published in the journal ‘Science Translational Medicine’.

more

Press contact

Birgit Niesing


+49 (0)89 3187-3971